CompletedN/AOther

The Multiple Sclerosis Continuous Quality Improvement (MSCQI) Collaborative

Sponsored by Dartmouth-Hitchcock Medical Center

NCT ID
NCT03480854
Target Enrollment
694 participants
Start Date
2017-07-01
Est. Completion
2020-12-31

About This Study

To establish the first systems level continuous quality improvement (CQI) collaborative for multiple sclerosis (MS) in the United States, to conduct benchmarking analyses and assessments of geographic variation in MS care quality and value, and study the effect of CQI interventions on improvement of selected performance (quality) indicators.

Conditions Studied

Multiple Sclerosis

Interventions

  • Quality Improvement

Eligibility

Age:18 Years - N/A
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* Adults aged 18 years or older with documented clinically confirmed MS who are followed by one of the participating MS centers.

Exclusion Criteria:

* Candidates will be excluded from study entry if they are unable or unwilling to provide informed consent.

Study Locations (4)

Neurology Associates of Greater Orlando
Maitland, Florida, United States
Massachusetts General Hospital Multiple Sclerosis Center
Boston, Massachusetts, United States
Concord Hospital
Concord, New Hampshire, United States
University of Vermont Multiple Sclerosis Center
Burlington, Vermont, United States

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source